Sofipôle SA
Cellaïon
We Care For The Liver,
We Care For
Lives
Cell Signaling Technology for Liver Repair
& Organ Regeneration
Vision
Cellaïon is a Belgian biotech company developing Life saving
advanced therapies to repair tissues and regenerate the liver, Cellaïon targets life threatening diseases.
Mission
We at Cellaion want to restore a favorable environment to reboost the regenerative process, and ensure a second life to the native liver instead of loosing it.
Lire la vidéo
Lire la vidéo
What we do
We repair tissues and regenerate organs using cell signaling technology
Our first target is the liver space. The liver is the master organ of the body, and loss of its function causes failure of other vital organs and death.
Cellaïon aims to stop progression of chronic liver disease, control inflammation, stop fibrous tissue accumulation and eventually allow organ recovery and
regeneration.
Personnal interest
you want to know more
about our last research or ACLF ?
Health professional
you want to know more
about our clinical study?
Pipeline
Clinical Trial / Publication
A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.
Published in April 2021 in JHEP Liver
Lire la vidéo
Latest news
Explore our selectrion of research articles and news
Investors
SMS Investments SA
Families Office
